Treatment of PAD by Platelet Lysate for Therapeutic Angiogenesis
NCT02941419 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2017-05-04
Summary
Induction of autologous angiogenesis in patients with critical limb ischemia using platelet lysate.
Conditions
- Critical Limb Ischemia
Interventions
- BIOLOGICAL
-
Platelet lysate
Autologous intramuscular platelet lysate injection for patients with peripheral arterial disease
Sponsors & Collaborators
-
University of Jordan
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-05
- Primary Completion
- 2016-09-15
- Completion
- 2017-02-09
More Related Trials
-
BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY
NCT02645799 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
NCT00059644 ·Status: TERMINATED ·Phase: PHASE3
-
Diabetic Artery Obstruction: is it Possible to Reduce Ischemic Events With Cilostazol?
NCT02983214 ·Status: COMPLETED ·Phase: PHASE4
-
Angiogenesis and Blood Perfusion Effect of HGF Gene Therapy in PAD Patients
NCT05968118 ·Status: UNKNOWN ·Phase: PHASE3
-
Cilostazol After Lower Extremity Arterial Revascularization Trial
NCT02374957 ·Status: TERMINATED ·Phase: PHASE4
-
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
NCT05009862 ·Status: COMPLETED ·Phase: PHASE4
-
Dietary Nitrate and Exercise to Augment Exercise Training Benefits in Subjects With DM+PAD
NCT01785524 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Feasibility Study of the Shockwave Lithoplasty System
NCT01577888 ·Status: COMPLETED ·Phase: NA
-
Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
NCT04277702 ·Status: UNKNOWN ·Phase: PHASE3
-
Platelet PAR-1 Activation in Health and Diabetes
NCT04280549 ·Status: COMPLETED
-
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
NCT02956993 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial Disease
NCT00059657 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions
NCT00566657 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Intermittent Claudication by G-CSF-mobilized PB-MNC
NCT03683628 ·Status: UNKNOWN ·Phase: NA
-
A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients
NCT01499420 ·Status: COMPLETED ·Phase: PHASE2
-
SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease
NCT02544204 ·Status: UNKNOWN ·Phase: PHASE2
-
Nitrites, Exercise, and Peripheral Arterial Disease
NCT01684930 ·Status: COMPLETED ·Phase: PHASE2
-
Carnosine for Peripheral Arterial Disease
NCT04870229 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease
NCT01702246 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans
NCT01067339 ·Status: COMPLETED ·Phase: PHASE3
-
PGD2 Formation in Vascular Injury
NCT01001260 ·Status: TERMINATED
-
Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease
NCT01983449 ·Status: COMPLETED ·Phase: PHASE4
-
Lp-PLA2 and Coronary Atherosclerosis in Humans
NCT01557088 ·Status: COMPLETED ·Phase: NA
-
Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction
NCT05217654 ·Status: UNKNOWN ·Phase: PHASE1
-
Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins
NCT00377806 ·Status: COMPLETED ·Phase: PHASE4